THE OVERVIEW OF STUDIES ON HUPERZINE A: A NATURAL DRUG FOR THE TREATMENT OF ALZHEIMER’S DISEASE - Medicinal Chemistry of Bioactive Natural Products - page 180

117. Zeng, F. X.; Jiang, H. L.; Tang, X. C.; Chen, K. X.; Ji, R. Y. Synthesis and acetylcho-
linesterase inhibitory activity of ( )-14-fluorohuperzine A. Bioorg. Med. Chem. Lett.,
1998, 8(13): 1661-1664.
118. Zhou, G. C.; Zhu, D. Y. Synthesis of 5-substituted analogues of huperzine A. Bioorg.
Med. Chem. Lett., 2000, 10(18): 2055-2057.
119. Hogenauer, K.; Baumann, K.; Mulzer, J. Synthesis of ( )-desamino huperzine A.
Tetrahedron Lett., 2000, 41(48): 9229-9232.
120. Hogenauer, K.; Baumann, K.; Enz, A.; Mulzer, J. Synthesis and acetylcholinesterase
inhibition of 5-desamino huperzine A derivatives. Bioorg. Med. Chem. Lett., 2001,
11(19): 2627-2630.
121. Tang, X. C.; Xu, H.; Feng, J.; Zhou, T. X.; Liu, J. S. Effect of cholinesterase inhibition in
vitro by huperzine A analogs. Acta Pharmacol. Sin., 1994, 15(2): 107-110.
122. Zhu, D. Y.; Tang, X. C., et al. Huperzine A derivatives, their preparation and their use.
European Patent, 0 806 416 B1,
123. Xiong, Z. Q.; Tang, X. C.; Lin, J. L.; Zhu, D. Y. Effects of isovanihuperzine A on
cholinesterase and scopolamine-induced memory impairment. Acta Pharmacol. Sin.,
1995, 16(1): 21-25.
124. Kozikowski, A. P.; Thiels, E.; Tang, X. C.; Hanin. In Maryanoff, B. E.; Maryanoff, C. A.,
editors. Advance in Medicinal Chemistry., vol. 1. Greenwich, CT: JAI Press; 1992, 175-205.
125. He, X. C.; Wang, Z. Y.; Li, Y. L.; Bai, D. L. Studies on analogues of huperzine A for the
treatment od Alzheimer's disease. I synthesis of 5-substituted aminomethyl-2(1H)-
pyridones

and 5-substituted amino-5,6,7,8-tetrahydroquinolones. Chinese J. Med.

Chem., 1994, 4: 257-262.
126. Fink, D. M.; Bores, G. M.; Effland, R. C.; Huger, F. P.; Kurys, B. E.; Rush, D. K.; Selk,
D. E. Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential
agents for the treatment of Alzheimer's disease. J. Med. Chem., 1995, 38(18): 3645-3651.
127. Wu, B. G. Ph. D thesis, Shanghai Institute of Materia Medica, Chinese Academy of
Sciences, 1996.
128. Wu, B. G.; Zhen, W. P.; Bo, Y. X.; He, X. C.; Bai, D. L. Synthesis of analogues of
huperzine A-3. The preparation of some single ring analogues of huperzine A. Chinese
Chem. Lett., 1995, 6(3): 193-196.
129. Wu, B. G.; Bai, D. L. Synthesis of huperzine A analogues. Chinese Pharm. J., 1995,
30(Suppl.): 63-66.
130. Camps, P.; Contreras, J.; Morral, J.; Munoztorrero, D.; Fontbardia, M.; Solans, X.
Synthesis of an 11-unsubstituted analogue of ( )-huperzine A. Tetrahedron, 1999,
55(28): 8481-8496.
131. Camps, P.; Munoztorrero, D.; Simon, M. Easy access to 4-substituted ( )-huperzine A
analogues. Synthetic Commun., 2001, 31(22): 3507-3516.
132. Badia, A.; Banos, J. E.; Camps, P.; Contreras, J.; Gorbig, D. M.; Munoztorrero, D.;
Simon, M.; Vivas, N. M. Synthesis and evaluation of tacrine-huperzine A hybrids as
acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's
disease. Bioorg. Med. Chem., 1998, 6(4): 427-440.
133. Carlier, P. R.; Du, D. M.; Han, Y. F.; Liu, J.; Pang, Y. P. Potent, easily synthesized
huperzine A-tacrine hybrid acetylcholinesterase inhibitors. Bioorg. Med. Chem. Lett.,
1999, 9(16): 2335-2338.